Threshold
Pharmaceuticals Announces Top-Line Phase II Clinical Trials
Results of Glufosfamide for Treatment of Pancreatic Cancer
December 27, 2006
Source: PharmaLive
Pancreatic
Cancer Treated By Gemcitabine Plus Cisplatin
October 26, 2006
Source: CancerCompass.com
Threshold
Pharmaceuticals Completes Enrollment in Phase 3 and Phase 2
Trials for the Treatment of Pancreatic Cancer
August 8, 2006
Source: Threshold Pharmaceuticals
Chemo-Radiation
After Surgery for Pancreatic Cancer May Prolong Survival
July 25, 2006
Source: cancerpage.com
Combination
Therapy May Improve Survival for Pancreatic Cancer
July 20, 2006
Source: Newswise.com
Gemzar®
Combined with Eloxatin® or Platinol® Improves Survival
for Patients with Advanced Pancreatic Cancer
June 2006 Source:
CancerConsultants.com
Addition
of Gemzar to Adjuvant Therapy Improves Survival in Pancreatic
Cancer
June 2006
Source: CancerConsultants.com
Pancreatic
Cancer With Gemcitabine Resistance Treated By Raltitrexed-eloxatin
Salvage Chemotherapy
May 18, 2006
Source: CancerCompass.com
New
Drug Combination Found to Be Effective in Gemcitabine-Resistant
Metastatic Pancreatic Cancer
April 18, 2006
Source: Pancreasweb.com
GEMOX
Active in Gemcitabine Refractory Pancreatic Cancer
March
10, 2006 Source: Pancreasweb.com
Temodar®
and Thalomid® Effective for Metastatic Neuroendocrine Tumors
March, 2006
Source: CancerConsultants.com
Tomudex®
Plus Eloxatin® Effective in Gemzar®-Resistant Metastatic
Pancreatic Cancer
March, 2006
Source: CancerConsultants.com
A
Multi-Institutional Phase II Trial of Preoperative Full-Dose
Gemcitabine and Concurrent Radiation for Patients with Potentially
Resectable Pancreatic Carcinoma
February, 2006
Source: Annals of Surgical Oncology on PubMed
Northwestern
Researchers Launch Avastin Trial for Pancreatic Tumors
February 22, 2006
Source: ScienceDaily
New
Study of Gemcitabine, Cisplatin and Bevacizumab Yields Promising
Results
February 3, 2006
Source: Pancreasweb.com
New
oral regimen active against pancreatic neuroendocrine tumors
February 1, 2006
Source: OncoLink
Gemcitabine
plus platinum analog extends life in pancreatic cancer
January 27, 2006
Source: OncoLink
5-fluorouracil
And Gemcitabine Enhance Gene Therapy in Pancreatic Cancer
January 26, 2006
Source: Cancer Compass
